Central Trust Company’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
Central Trust Company's LMAT Position: Q3 2026 in Review
Central Trust Company held its LeMaitre Vascular (LMAT) position steady in Q3 2026 at 7 shares worth $579. The position accounts for ﹤0.01% of the portfolio, ranked #1517.
Central Trust Company first reported a position in LMAT in Q1 2022 and has held it in 12 quarters since. The position peaked at $3.77K in Q2 2023. 298 funds tracked by Wall St. Rank hold LMAT as of Q3 2026.
- Central Trust Company held 7 shares of LeMaitre Vascular worth $579 as of Q3 2026.
- Central Trust Company left its LeMaitre Vascular share count unchanged in Q3 2026.
- LeMaitre Vascular made up ﹤0.01% of Central Trust Company's portfolio in Q3 2026, its #1517 holding.
- Central Trust Company first reported a position in LeMaitre Vascular in Q1 2022 and has held it in 12 quarters since.
- Central Trust Company's LeMaitre Vascular position peaked at $3.77K in Q2 2023.
- 298 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2026.
Based on Central Trust Company's 13F filing for Q3 2026, filed 5 Nov 2026.